Skip to main content
. Author manuscript; available in PMC: 2010 Feb 3.
Published in final edited form as: Cancer Cell. 2009 Feb 3;15(2):135–147. doi: 10.1016/j.ccr.2008.12.016

Figure 7. CD15 is expressed in human medulloblastoma and expression of a CD15-associated gene signature predicts survival.

Figure 7

(A) Variable immunoreactivity for CD15 in a classic medulloblastoma. (B) CD15 immunoreactivity in the matrix of a nodule in a medulloblastoma with extensive nodularity. (C) Strong immunoreactivity for CD15 in clusters of tumor cells in a large cell medulloblastoma (Scale bars = 70 μm for all panels). (D) Increased probability of CD15+ signature correlates with poor survival in human medulloblastoma. Black tick marks represent surviving patients at time of last follow-up. Log rank for trend p = 0.02.